VV Shots Citigroup (NYSE:C) has been the clear laggard of the big U.S. banks since the Financial Crisis. It was a poorly constructed collection of businesses, run inefficiently for decades. With that said, there have been opportunities to make a lot of money in the stock by buying at sizeable discounts to tangible book value,…
JHVEPhoto/iStock Editorial via Getty Images Investment Thesis My investment thesis for TriNet Group, Inc. (NYSE:TNET) hinges on customer growth, particularly in Worksite Employees (WSEs). Zenefits has opened up a new market for TriNet while improving the PEO business. New sales growth and retention improvement will be the foundation upon which TriNet can deliver market-beating returns….
Rob Daly/OJO Images via Getty Images Overview My recommendation for DocuSign (NASDAQ:DOCU) is a neutral rating, as I still do not have any confidence that growth could accelerate in FY25, despite the positive headline revenue and billings growth. My assessment shows that revenue growth still tracks poorly vs. history, and like-for-like billings growth remains weak…
We Are Investment action Based on my current outlook and analysis of Yext (NYSE:YEXT) stock, I recommend a hold rating. While I see aspects of growth inflection and upside, I think it is best to wait for YEXT to actually show growth inflection at the topline to take a more convicted view of the stock….
Vertigo3d/iStock via Getty Images MacroGenics (NASDAQ:MGNX) is an important biotech to keep an eye on, because it has been able to make remarkable progress on advancing the use of its lead drug vobra duo [vobramitamab duocarmazine] in the ongoing phase 2 TAMARACK study for the treatment of patients with metastatic castration-resistant prostate cancer [mCRPC]. It…
Auris A “show me” stock AT&T Inc. (NYSE:T) has largely become a “show me” stock recently, in my view. That is, I think investors are saying “show me” the results before they’re convinced to buy in. Of course, there are good reasons. It’s difficult to argue against the attractiveness of the company’s stock price (a…
Jacob Wackerhausen/iStock via Getty Images CervoMed (NASDAQ:CRVO) has been enrolling for its phase 2b RewinD-LB study, which is using neflamapimod for the treatment of patients with dementia with Lewy bodies [DLB]. The reason to note this biotech is that it had stated that it is on track to complete enrollment of this trial in the…
NUTCHAPONG WUTTISAK/iStock via Getty Images HilleVax, Inc. (NASDAQ:HLVX) is gearing up to report a critical catalyst in the coming months, which is going to provide significant proof of whether or not its Virus Like Particle [VLP] HIL-214 can prevent moderate-to-severe Norovirus-related acute gastroenteritis. In particular, it expects to report results from a phase 2/3 study…
manassanant pamai Episode Description: Long regarded as an undervalued and overlooked market, Japan has been undergoing a profound transformation. The renewed interest in this market stems from a variety of factors – including revamped investor sentiment, evolving macroeconomic conditions and compelling corporate reforms. Will Japan be able to live up to its potential and redefine…
JONGHO SHIN Why did Affirm shares treble in 2 months; what’s up next Affirm (NASDAQ:AFRM) shares really did treble in the last two months without a whole lot of support from brokerage analysts or from commentators on SA. The shares currently are still rated as somewhat below a hold on average: out of 19 brokerage…
e-crow Introduction Last year presented a checkered landscape for the oilfield equipment and services industry, with the U.S. market experiencing notable weaknesses, contrasted by robustness in international and offshore sectors. Despite these challenges, NOV Inc. (NYSE:NOV) didn’t just hold its ground; it thrived, as its earnings were buoyed by solid international and offshore demand —…
Petmal Here at the Lab, since our publication on Superchargers And Electric Vehicles called Chickens And Eggs released in 2020, we have had a positive view of the Battery Energy Storage System companies. In our last analysis, we recently reported how Stem (NYSE:STEM) was On Track For A Positive 2023 H2; however, looking back to…
Klaus Vedfelt I updated Airbnb, Inc. (NASDAQ:ABNB) investors in early September, explaining that ABNB’s recovery seems robust, although the market had likely priced in its entry into the S&P 500 (SPX) (SPY). As a result, I urged investors to consider waiting for a steep pullback before considering the appropriate levels to add exposure. That thesis…
champc A couple of noteworthy items to mention from last week before we jump into a deeper dive of the S&P 500 charts. First, on Friday, Moody’s Investors Service (Moody’s) changed the outlook on the Government of United States of America’s (US) ratings to negative from stable. This would suggest that Moody’s is contemplating downgrading…
dem10 Block (NYSE:SQ) submitted a strong earnings sheet for the third quarter that showed continual gross profit momentum, especially in the Cash App business. The Cash App is Block’s most promising and fastest-growing segment which generated more than 27% gross profit growth in Q3’23. As FinTech scales its product offerings, signs on new customers to…
JuSun Archer-Daniels-Midland (NYSE:ADM) is a company I have mentioned at various times over my 10 years writing on Seeking Alpha. The most bullish stories were posted after the pandemic selloff, represented by this March 2020 effort here. As explained in my articles, right on cue – extraordinary money printing by the Federal Reserve (and central…
Sabine Hortebusch/iStock via Getty Images The Inflection Point An inflection point is a moment in time when small but critical events determine long term trends. We think today is such a moment (red circle) and is defined by this question: “Is the recent, two month, 8% decline just a normal correction in a bull market…
ABBPhoto/iStock via Getty Images Intro If we pull up a technical chart of 374Water, Inc. (NASDAQ:SCWO), we see that shares recently printed a bearish moving average crossover by means of the stock’s 10-week average moving below its 40-week counterpart. Although the intermediate downtrend has been weakening (as we see through the rising histogram), shares do…
hapabapa Online real estate platform Zillow Group, Inc. (NASDAQ:Z) has suffered share price weakness after the presentation of the firm’s second-quarter results. I believe the drop in valuation is a strong buying opportunity for long term oriented investors. Zillow could soon achieve an inflection point (GAAP profitability) and falling interest rates could recharge Zillow’s real…
Inna Dodor/iStock via Getty Images Topline Summary It’s been a long time since I had a first look at Inovio Pharmaceuticals (NASDAQ:INO) on Seeking Alpha, and back then we were still mired deeply in COVID-19 uncertainty, and INO had made big strides in terms of valuation based on a DNA vaccine. I suggested you keep…
RHJ Overview and recent performance of palladium Since our initial bullish stance on the abrdn Physical Palladium Shares ETF (NYSEARCA:PALL) on February 15, 2023, palladium prices have declined, resulting in PALL shedding about 17% of its value. While we previously expected both macro and fundamental dynamics to bolster palladium prices, macro conditions have remained stable,…
halbergman Glass House Brands (OTC:GLASF) is a cannabis producer and distributor operating in California. We think that their strategy and proven execution make this player a good pick for acquiring some exposure to this growing and changing trend. Also, the relatively early stage of the company and being close to a turning point makes the…
gremlin After the 2Q23 results, I am growing my confidence in Mobileye (NASDAQ:MBLY). Because Mobileye is somewhat in an early stage of its development with SuperVision only having one main customer in 2Q23, the current 2Q23 quarter is not a very good reflection of the company, in my view. The main thing to look at…
metamorworks Reviewing Tenable: a leader in ‘Cyber Exposure’ technology Cyber-Exposure is perhaps not the best sounding tag lines I have ever seen in the IT space. The company uses that phrase as shorthand for what it does. It is better described as the leader in the Vulnerability Management space and that is a decent position…
JD.com (NASDAQ:JD) has often been ignored by American investors. The company often seems like the not so famous cousin of (BABA). Typically, the stock has been a bargain though under $35. The last time we bought JD was in 2020 for around $34 and watched it make a huge run before selling in 2021 for…